financetom
Business
financetom
/
Business
/
Trump tariffs to reduce US deficits by $1 trillion less than previous estimate, CBO says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump tariffs to reduce US deficits by $1 trillion less than previous estimate, CBO says
Nov 20, 2025 2:16 PM

WASHINGTON (Reuters) -President Donald Trump's tariff increases on imports from foreign countries will reduce U.S. deficits by $3 trillion if they are maintained through 2035, the non-partisan Congressional Budget Office estimated on Thursday, instead of the $4 trillion the agency projected in August.

The CBO based its latest estimate on tariffs imposed by Trump between January 6 and November 15. It said that primary deficits would be reduced by $2.5 trillion over 11 years, with government borrowing costs falling by around $500 billion as a result. The August estimate was $3.3 trillion and $700 billion, respectively.

The revision was mainly based on new data, with the remainder stemming from the Trump administration's recent changes to its tariff policies.

Some federal courts have ruled that the administration overstepped its authority in imposing the tariffs, as the U.S. Constitution grants Congress powers over trade policy. The U.S. Supreme Court is reviewing those decisions.

Trump has boasted that the tariffs have created a windfall for the U.S. Treasury, while critics argue the higher costs of goods arriving from abroad are passed on to consumers in the form of higher prices on products when they reach American shelves.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Viatris Says EFFEXOR Met Primary Endpoint of Reducing Anxiety Symptoms in Phase 3 Trial
Viatris Says EFFEXOR Met Primary Endpoint of Reducing Anxiety Symptoms in Phase 3 Trial
Oct 10, 2024
07:58 AM EDT, 10/09/2024 (MT Newswires) -- Viatris ( VTRS ) said Wednesday its phase 3 trial in Japan evaluating EFFEXOR for generalized anxiety disorder met its primary objective, showing superiority over placebo in reducing anxiety symptoms at eight weeks. The trial, which assessed 804 patients, met primary and all secondary efficacy endpoints, Viatris ( VTRS ) said. EFFEXOR was...
AECOM Says It Has Been Selected as Design Partner for Southern Water's Capital Delivery Program
AECOM Says It Has Been Selected as Design Partner for Southern Water's Capital Delivery Program
Oct 10, 2024
07:33 AM EDT, 10/09/2024 (MT Newswires) -- AECOM ( ACM ) said Wednesday that two contractors have selected it to assist Southern Water with its $4.8 billion capital delivery program. In one of the agreements, AECOM ( ACM ) will be a detailed design partner for Kier, alongside Pell Frischmann, on various non-infrastructure water and wastewater projects. Meanwhile, Morrison Water...
BRIEF-Ceribell Inc Expects IPO Price To Be Between $16.00 And $17.00 Per Share
BRIEF-Ceribell Inc Expects IPO Price To Be Between $16.00 And $17.00 Per Share
Oct 10, 2024
Oct 9 (Reuters) - * CERIBELL INC SAYS NOW EXPECTS IPO PRICE TO BE BETWEEN $16.00 AND $17.00 PER SHARE - SEC FILING * CERIBELL INC - NOW SEES IPO OF UP TO 10.6 MILLION SHARES OF COMMON STOCK * CERIBELL INC SAYS IT HAD PREVIOUSLY EXPECTED IPO OF UP TO 6.7 MILLION COMMON SHARES TO BE PRICED BETWEEN $14...
Well Health Announces
Well Health Announces "Positive Findings" from OntarioMD AI Scribe Evaluation Study
Oct 10, 2024
07:30 AM EDT, 10/09/2024 (MT Newswires) -- WELL Health Technologies ( WHTCF ) on Wednesday said the final report from the AI Scribe Evaluation Study, conducted by OntarioMD, a subsidiary of the Ontario Medical Association, has been published. The study involved testing several AI scribes, including WELL's AI Voice (WAIV) solution, with 152 primary care providers across the province. It...
Copyright 2023-2026 - www.financetom.com All Rights Reserved